Federal Government Newsletter – Issue #1
Medidata's Approach to Supporting the Federal Government
Bringing Market Research to your inbox spreading awareness of how Medidata supports Federal Clinical Trials
Select the topic below to be directed straight to the content:
Welcome to Medidata
Why Medidata for Federal Clinical Research?
FedRAMP Authorization
NEXT New York 2024
How Frontier Responded to COVID-19 to Keep Trials Moving
How does Medidata Support Beyond Providing an EDC?
Knowledge Hub: What's New
Welcome to Medidata
End-to-End Clinical Trial Ecosystem
Medidata recently hit its 25-year anniversary as it supports bringing life-saving therapies to patients and improving our nation’s understanding of disease progression. In the late 1990s, Medidata’s Glen de Vries and Tarek Sharif built one of the first Electronic Data Capture systems which went on to become a market leading EDC in both commercial and academic markets.
To date, Medidata has supported over 33,000 clinical trials across the entire clinical trial workflow including data management, clinical operations, patient engagement and advanced analytics.
Why Medidata for Federal Clinical Research?
Experience Matters.
Medidata has spent nearly two decades supporting federal government sponsors when it comes to clinical research. Currently, we have two long-standing partnerships with the National Cancer Institute and the National Institute of Allergies and Infectious Disease. The purpose of this newsletter is to proactively bring market research to your inbox so you can stay informed on Medidata’s latest technical innovations embedding AI into everything we do as well as our dedicated focus to academic clinical trials from a personnel, pricing and security standpoint.
FedRAMP Authorization
Medidata recognizes the importance of data security for Federal agencies. Because of this, we are proud to announce our pursuit of FedRAMP authorization. While this process is currently underway, we are happy to schedule some time to discuss any questions you may have about this and general inquiries about how we can support your clinical trials.
Upcoming Event
NEXT New York 2024
Medidata NEXT returns to the Sheraton New York Times Square on November 13–14. And we’re bringing the unmistakable energy and innovation that makes NEXT so special. The biggest life sciences names, the most pressing topics—all tied together by immersive clinical trial experiences.
Come together with your peers to share solutions to life sciences’ biggest challenges, learn from top organizations, and explore how technology is improving clinical research across all stakeholders—from patients, to sites, to sponsors, and CROs.
How Frontier Responded to COVID-19 to Keep Trials Moving
Case Study
Frontier Science Foundation needed a quick pivot to address a pandemic challenge: Despite shutdowns affecting onsite study monitoring, they were committed to continuing the science. Frontier Science is a not-for-profit organization collaborating with research networks and sponsors to conduct clinical trials. Frontier Science has been involved in research for the past four decades and its work has significantly advanced the development of HIV/AIDS and oncology therapies. When Frontier Science suddenly needed to implement remote study monitoring, they turned to Medidata for a technology solution.
How Does Medidata Support Beyond Providing an EDC?
Q&A Section
Medidata’s Rave EDC is well-established in the clinical trial community. However, our solutions expand far beyond Rave EDC including data management, clinical operations, patient engagement and advanced analytics solutions.
Additionally, Medidata provides implementation, enablement, support and consulting services as well.
Knowledge Hub: What’s New
When you search Medidata’s product documentation on the Knowledge Hub, do you always use the same filters to narrow your search results? Check out the latest Knowledge Hub blog post on setting your search preferences and find the content you need even faster!
Clinical Minds Blog
Be sure to bookmark the Clinical Minds Blog webpage and check back frequently for our latest industry insights.
Subscribe to Medidata MediVoice, our LinkedIn newsletter for the latest patient insights and clinical innovations.
Meet Your Subject Matter Experts
Name & Title: Toni-Ann Dickenson, PMP - Senior Solution Consultant at Medidata
Biography: With over 6 years of experience in the life sciences industry, I have had the privilege of working across the pharmaceutical, academic, federal, and medical device sectors. My journey began at Indiana University of Pennsylvania (IUP), where I majored in Natural Science and minored in Chemistry, followed by a semester studying Psychology in Leeds, UK. I started my career at Celgene (BMS) on the Process & Technology team, supporting all operations within the CAR T sector, which ignited my passion for patient-centered solutions.
For the past 3 years, I have been a Solution Consultant at Medidata, where I collaborate with clients to streamline clinical trials and enhance patient outcomes. Throughout my career, I’ve supported projects in cell and gene therapies, women’s health, rare diseases, and various other therapeutic areas. I’ve gained valuable insights from my experience in medical affairs, data management, patient diversity, supply chain, global manufacturing operations, and GxP regulations, equipping me with the knowledge needed for successful clinical trials.
Primary Product Focus Area: Data Management
Accolades: President’s Club Winner (2022), Excellence in Delivering Exceptional Results - BMS (2020), Top 10 Pharma Award (2020)
Expertise:
- 6+ years in life sciences
- Medical affairs, global manufacturing, supply chain operations, quality operations, IMAPs, data management, and GxP regulations and guidelines
Passions: Outside of tackling trial challenges, I enjoy coaching a U8 boy’s soccer team, exploring the world through travel and languages, and taking on exciting DIY projects. I’m also recently looking to participate in more outdoor adventures, like ATVing and snowmobiling, after experiencing these activities in Alaska. At home, my 3-year-old standard poodle, Kingsley, reigns as the king of the house—I'm always happy to share pictures of him!